Newly-diagnosed Pediatric T-cell ALL Protocol

Clinical trial NCT06855810 · RECRUITING

Trial details

NCT number: NCT06855810
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Childhood Leukemia, Acute Lymphoblastic T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma

Start date: 2025-03-11
Primary completion: 2030-06-01
Enrollment: 610

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.